FIGO III-IV stage and with ER+ and/or PgR+ after primary surgery are eligible., Patients with a low-grade serous epithelial carcinoma of the ovary (LGSCO) including cancer of fallopian tube and peritoneum
Conditions
Brief summary
The primary endpoint is PFS, defined for each patient as the time from the date of randomization to the date of local or regional relapse, distant metastasis, or death from any cause, whichever comes first.
Detailed description
Objective Response Rate (ORR), defined as the percentage of patients with an objective response determined by a complete response (CR) or a partial response (PR) as determined by RECIST 1.1.
Interventions
DRUGLetrix 2
DRUG5 mg compresse rivestite con film.
DRUGCARBOPLATIN
DRUGPACLITAXEL
Sponsors
Ente Ospedaliero Ospedali Galliera Di Genova
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is PFS, defined for each patient as the time from the date of randomization to the date of local or regional relapse, distant metastasis, or death from any cause, whichever comes first. | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective Response Rate (ORR), defined as the percentage of patients with an objective response determined by a complete response (CR) or a partial response (PR) as determined by RECIST 1.1. | — |
Countries
Italy
Outcome results
None listed